June 6, 2013
The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
Partnership Seeks to Accelerate Development of Innovative Therapies. Read More
June 5, 2013
LLS applauds FDA approval of lenalidomide for patients with relapsed or refractory mantle cell lymphoma (MCL)
Approval marks first oral therapy for MCL patients, and a new option for patients with unmet medical need. Read More
